Brings New Hope to Advanced Breast Cancer Patients with breakthrough drug
GlaxoSmithKline (GSK) announced today an important milestone for advanced breast cancer patients in the Philippines with the launch of lapatinib, a drug that has shown to significantly slow down the progression of advanced breast cancer which has progressed following treatment with other cancer therapies.

It also has leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic, where its class-leading prescription medicines help alleviate the suffering of millions of people around the world.

Products
For the families living in Barangay Sta. Ana in Pateros, it was like having Christmas in March as GlaxoSmithKline (GSK) supported Mercury Drug's "Operation Bigay Lunas" in providing quality and affordable medicines to their community.
Aside from Pateros, residents from 10 other sites in Edsa Munoz, Sta. Cruz, Cainta, Cavite and even as far away as Isabela, Palawan, Dagupan, Zambales and Iloilo packed Bigay Lunas venues set up in their respective hometowns to avail of free health consultation and check-ups provided onsite. To ensure that residents get the treatment they need, medicines known for their trusted brands and quality were provided to them for free. Through the health service and medicines provided, members of the community were able to take responsibility for their health and treat common ailments such as cough, bacterial infections and asthma.
News

GlaxoSmithKline's commitment extends beyond medical laboratories and research facilities. The Company has always been committed to community service, extending both medical expertise and employee involvement in the communities where they operate.

For more info, go to GSK Foundation